z-logo
open-access-imgOpen Access
Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate
Author(s) -
Kathryn Lurain,
Thomas S. Uldrick,
Ramya Ramaswami,
Mark N. Polizzotto,
Priscila Gonçalves,
Anaida Widell,
Seth M. Steinberg,
Elaine S. Jaffe,
Stefania Pittaluga,
HaoWei Wang,
Constance M. Yuan,
Mary Anne Tamula,
Staci Martin,
Pamela L. Wolters,
Jomy George,
Richard F. Little,
Robert Yarchoan
Publication year - 2020
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2020006048
Subject(s) - rituximab , medicine , primary central nervous system lymphoma , methotrexate , lymphoma , antiretroviral therapy , immunology , human immunodeficiency virus (hiv) , oncology , viral load

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom